New Key Statistics Module, Z-Score and F-Score
NAS:EGRX Key Ratios
| Market Cap $ M | 60.00 |
| Enterprise Value $ M | 117.81 |
| P/E(ttm) | 5.12 |
| PE Ratio without NRI | 2.14 |
| Forward PE Ratio | -- |
| Price/Book | 0.24 |
| Price/Sales | 0.24 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 257.00 |
| EPS (TTM) $ | 0.91 |
| Beneish M-Score | -1.9 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -25.10 |
| y-y EBITDA Growth Rate % | 18.40 |
| EV-to-EBIT | 3.30 |
| EV-to-EBITDA | 2.09 |
| PEG | -- |
| Shares Outstanding M | 12.96 |
| Net Margin (%) | 4.64 |
| Operating Margin % | 15.92 |
| Pre-tax Margin (%) | 11.33 |
| Quick Ratio | 1.67 |
| Current Ratio | 2.16 |
| ROA % (ttm) | 3.00 |
| ROE % (ttm) | 4.99 |
| ROIC % (ttm) | 5.79 |
| Dividend Yield % | -- |
| Altman Z-Score | 1.89 |
EGRX Number of Guru Trades
EGRX Volume of Guru Trades
Gurus Latest Trades with NAS:EGRX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:EGRX is held by these investors
Total 2
Eagle Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:EGRX
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers